Intervensi pada Populasi Risiko Tinggi Skizofrenia, Perlukah?
Downloads
Schizophrenia is a mental disorder with severe and persistent manifestation of psychosis symptoms chronically which patient of Schizophrenia are administered to health facilities very late. Almost people do not recognize the first symptoms even though client has genetic of Schizophrenia. There are strategies and interventions have been used to increase the number of disability. The researchers give omega-3, supportive psychotherapy and family therapy they also consider atypical antipsychotic as preventive but it still controversy.
Carrión, R. E., Correll, C. U., Auther, A. M., & Cornblatt, B. A. (2017). A severity-based clinical staging model for the psychosis prodrome: Longitudinal findings from the New York recognition and prevention program. Schizophrenia Bulletin, 43(1), 64–74. https://doi.org/10.1093/schbul/sbw155.
Cornblatt, B. A., Carrión, R. E., Auther, A., McLaughlin, D., Olsen, R. H., John, M., & Correll, C. U. (2015). Psychosis prevention: A modified clinical high risk perspective from the recognition and prevention (RAP) Program. American Journal of Psychiatry, 172(10), 986–994. https://doi.org/10.1176/appi.ajp.2015.13121686.
Fusar-Poli, P. (2017). The clinical high-risk state for psychosis (CHR-P), Version II. Schizophrenia Bulletin, 43(1), 44–47. https://doi.org/10.1093/schbul/sbw158.
Fusar-Poli, P., Yung, A. R., McGorry, P., & Van Os, J. (2014). Lessons learned from the psychosis high-risk state: Towards a general staging model of prodromal intervention. Psychological Medicine, 44(1), 17–24. https://doi.org/10.1017/S0033291713000184.
Iyer, S., Jordan, G., Macdonald, K., Joober, R., & Malla, A. (2015). Early intervention for psychosis: A Canadian perspective. Journal of Nervous and Mental Disease, 203(5), 356–364. https://doi.org/10.1097/NMD.0000000000000288.
Joa, I., Gisselgård, J., Brí¸nnick, K., McGlashan, T., & Johannessen, J. O. (2015). Primary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian ultra high risk study. BMC Psychiatry, 15(1), 1–9. https://doi.org/10.1186/s12888-015-0470-5.
Kahn, R. S., & Sommer, I. E. (2015). The neurobiology and treatment of first-episode schizophrenia. Molecular Psychiatry, 20(1), 84–97. https://doi.org/10.1038/mp.2014.66.
Kirkbride, J. B., Hameed, Y., Ankireddypalli, G., Ioannidis, K., Crane, C. M., Nasir, M., Jones, P. B. (2017). The epidemiology of first-episode psychosis in early intervention in psychosis services: Findings from the sosial epidemiology of psychoses in east Anglia [SEPEA] Study. American Journal of Psychiatry, 174(2), 143–153. https://doi.org/10.1176/appi.ajp.2016.16010103.
Kurachi, M., Takahashi, T., Sumiyoshi, T., Uehara, T., & Suzuki, M. (2018). Early intervention and a direction of novel therapeutics for the improvement of functional outcomes in schizophrenia: A selective review. Frontiers in Psychiatry, 9(FEB), 1–11. https://doi.org/10.3389/fpsyt.2018.00039.
Langer, Á. I., Schmidt, C., Mayol, R., Díaz, M., Lecaros, J., Krogh, E., Gaspar, P. A. (2017). The effect of a mindfulness-based intervention in cognitive functions and psychological well-being applied as an early intervention in schizophrenia and high-risk mental state in a Chilean sample: Study protocol for a randomized controlled trial. Trials, 18(1), 1–9. https://doi.org/10.1186/s13063-017-1967-7.
Laurens, K. R., & Cullen, A. E. (2016). Toward earlier identification and preventative intervention in schizophrenia: evidence from the London Child Health and Development Study. Sosial Psychiatry and Psychiatric Epidemiology, 51(4), 475–491. https://doi.org/10.1007/s00127-015-1151-x.
Lieberman, J. A., Girgis, R. R., Brucato, G., Moore, H., Provenzano, F., Kegeles, L., Small, S. A. (2018). Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention. Molecular Psychiatry, 23(8), 1764–1772. https://doi.org/10.1038/mp.2017.249.
McGorry, P. D. (2015). Early intervention in psychosis: Obvious, effective, overdue. Journal of Nervous and Mental Disease, 203(5), 310–318. https://doi.org/10.1097/NMD.0000000000000284.
Riskesdas. (2018). Hasil Utama Riskesdas 2018. http://www.depkes.go.id/resources/download/infoterkini/materi_rakorpop_2018/Hasil%20Riskesdas%202018.
Saddock, B.J., Virginia. A.S. & Ruiz. P. (2018). Kaplan and Sadock's Comprehensive Textbook of Psychiatry 10th edition. Schizophrenia pages 225-230.
Schmidt, S. J., Schultze-Lutter, F., Schimmelmann, B. G., Maric, N. P., Salokangas, R. K. R., Riecher-Rössler, A., ... Ruhrmann, S. (2015). EPA guidance on the early intervention in clinical high risk states of psychoses. European Psychiatry, 30(3), 388–404. https://doi.org/10.1016/j.eurpsy.2015.01.013.
Schultze-Lutter, F., Michel, C., Schmidt, S. J., Schimmelmann, B. G., Maric, N. P., Salokangas, R. K. R., ... Klosterkötter, J. (2015). EPA guidance on the early detection of clinical high risk states of psychoses. European Psychiatry, 30(3), 405–416. https://doi.org/10.1016/j.eurpsy.2015.01.010.
Seidman, L. J., & Nordentoft, M. (2015). New Targets for Prevention of Schizophrenia: Is It Time for Interventions in the Premorbid Phase? Schizophrenia Bulletin, 41(4), 795–800. https://doi.org/10.1093/schbul/sbv050.
Sommer, I. E., Bearden, C. E., Van Dellen, E., Breetvelt, E. J., Duijff, S. N., Maijer, K., Vorstman, J. A. S. (2016). Early interventions in risk groups for schizophrenia: What are we waiting for? Npj Schizophrenia, 2(December 2015). https://doi.org/10.1038/npjschz.2016.3.
Stahl, S.M. (2018). Stahl's Essential Psychopharmacology Neuroscientific Basis and Practical Application Fourth Edition. Psychosis and Schizophrenia Pages 114-119.
Copyright (c) 2019 Ayu Nuzulia Putri, Sasanti Yuniar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. Copyright of this journal is possession of the Author, by the knowledge of the Editorial Board and Journal Manager, while the moral right of the publication belongs to the author.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The articles are published under a Creative Commons Attribution Share-Alike (CC BY-SA) license. Many research funding bodies prefer the CC BY-SA license because it allows for maximum dissemination and re-use of open access materials. Users are free to share (copy, distribute, and transmit) and remix (adapt) the contribution under this license, including for commercial purposes, as long as they attribute the contribution in the manner specified by the author or licensor.
